4.8 News Item

Long COVID's long R&D agenda

Journal

NATURE REVIEWS DRUG DISCOVERY
Volume 20, Issue 5, Pages 329-331

Publisher

NATURE PORTFOLIO
DOI: 10.1038/d41573-021-00069-9

Keywords

-

Ask authors/readers for more resources

Researchers are conducting a pioneering trial to test treatments addressing long-term complications of infection in previously hospitalized individuals with post-acute COVID-19.
As researchers work to understand the biology and epidemiology of post-acute COVID-19, a pioneering platform trial is now testing treatments to try to address the long-term complications of infection in previously hospitalized individuals. As researchers work to understand the biology and epidemiology of post-acute COVID-19, a pioneering platform trial is now testing treatments to try to address the long-term complications of infection in previously hospitalized individuals.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available